The SAGE Handbook of Drug & Alcohol Studies

Inhaltsverzeichnis

Section One: Determination of Substance Misuse
1. Genetics and genomics in addiction research - Rohit Jaibhagwan Lodhi, David Rossolatos and Katherine Jean Aitchison
2. Basic Pharmacokinetics of Substance Misuse - Kim Wolff
3. Future Directions: The role of pharmacogenomics - Jason White & Andrew Somogyi
Section Two: PK and PD in Relation to Patterns of Use
4. Alcohol: Pharmacokinetics and Pharmacodynamics - Matthew Goldin and E Jane Marshall
5. Nicotine: The Pharmacokinetics of Nicotine and Cotinine - Noor Robson
6. Emerging Tobacco Trends from the Arabian Cultures (Waterpipe and Dokha): Global Prevalence, Health Risks and Propensity for Abuse - Annie Crookes
7. Opioids: A Discussion of Pharmacokinetics and Pharmacodynamics of Opioids in Those Who Misuse Drugs - Verena Metz & Sandy Corner
8. Cocaine: pharmacokinetics, pharmacodynamics and addictive potential - Glenn Dumont
9. Amphetamine & Methamphetamine: Pharmacokinetics and Pharmacodynamics - Kim P.C. Kuypers, Eef Theunissen and Jan Ramaekers
10. MDMA: Pharmacokinetics - Magí Farré, Esther Papaseit & Rafael de la Torre
11. Benzodiazepines: A discussion of pharmacokinetic and pharmacodynamic effects in those who misuse the drug - Alyson Bond & Malcolm Lader
12. Ketamine: the pharmacokinetics and pharmacodynamics in medicinal and misusing populations - Kim Wolff
13. Cannabis: The pharmacokinetics and pharmacodynamics of recreational and medicinal cannabis - Dave Allsop, Richard Kevin & Jonathon Arnold
14. Synthetic cannabinoids: The pharmacokinetics and pharmacodynamics of 'Spice' and other synthetic cannabinoids - Deepak D'Souza & Aarti Gupta
15. Khat, Methedrone and MDPV: A discussion of pharmacokinetic and pharmacodynamic parameters - Lorenza Colzato & Manuel Ruiz
16. Gamma-hydroxybutyric Acid (GHB): A discussion of pharmacokinetic and pharmacodynamic effects of GHB including its analogues - John B. Saunders, Jason Connor & Gerald Feeney
17. Polysubstance Use - Jason Connor, John Saunders, Adrian Kelly, Gerald Feeney
Section Three: Detection and Treatment of Drug and Alcohol Use
18. A brief overview of the detection of drug and alcohol use: the matching of purposes and procedures. - Kim Wolff & Michael Gossop
19. Biomarkers of drug use - Kim Wolff & Michael Gossop
20. Biomarkers of alcohol use - Natalie E Walsham & Roy A Sherwood
21. Pharmacotherapy: What works - John Witton
22. Treatment of Opioid Dependence - Kim Wolff, Steven Karch, Jason White
23. Wastewater Analysis for the Measurement of Population Level Drug Use: Sewage-Based Epidemiology - Bram Miserez & Alexander van Nujs
Section Four: Special Settings
24. Forensic and postmortem toxicology - A Robert Forrest
25. The workplace: alcohol use disorders and convictions for alcohol-related offences - Kim Wolff, Samantha Gross, Noor Zurani-Robson and Jane Marshall
26. Future directions: What is the way forward for toxicology and forensic research? - Steven B Karch
Section Five: Controversies and New Approaches
27. Intravenous abuse of methylphenidate - Bjarni O. Rafnar and Gudrun Dora Bjarnadottir
28. Non addictive drug use: The way forward - Christian P. Müller
29. Different Approaches to setting limits for drugs and alcohol use when driving - Kim Wolff
30. Where do gambling and internet 'addictions' belong? The status of 'other' addictions - Mark D. Griffiths, Daria J. Kuss, Halley M. Pontes and Joël Billieux
31. The treatment of benzodiazepine dependence: Maintenance or abstinence? - Deborah Zador
32. ADHD: Pathway into Addiction, Option for Treatment? - Pieter-Jan Carpentier, Philip Asherson & Ulrich Muller
33. Attention Deficit Hyperactivity Disorder and its association with Substance Use - Susan Young & Ottilie Sedgwick